The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

As one of the world’s largest biopharma companies, Pfizer ($PFE) is no stranger to leveraging market dynamics to benefit the company and its ...

Shares of GSK rallied for a third straight day on Tuesday to hit a new all-time high, as investors gobbled up shares in ...

Outgoing CEO Walmsley's bold R&D push ignites investor buzz as AstraZeneca and GSK shares jump on deal optimism ...

GSK is "betting big on the US" and engaged in "constructive" talks on drug pricing with President Donald Trump's ...

Emma Walmsley was the first woman to hold the CEO post at the Big Pharma company.

GSK Plc is “betting big on the US” and engaged in constructive talks on drug pricing with US President Donald Trump’s administration, according to Emma Walmsley, the outgoing chief executive officer ...

The agreement, seen as less punishing than some within the industry had feared, gives hard-hit global drugmakers a degree of ...

McCarter & English launched a wave of patent infringement lawsuits on behalf of biotech giants in Delaware federal court this ...

CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this ...

GENEVA (Reuters) -Swiss drugmakers could strike their own deals with the U.S. after President Donald Trump's push to lower ...